Expanding the Ventricular Assist Device (VAD) Market Growth Trends and Future Projections

The global Ventricular Assist Device (VAD) market, valued at USD 1.59 billion in 2023, is poised for robust expansion. Projections indicate the market will reach USD 3.08 billion by 2032, driven by a steady compound annual growth rate (CAGR) of 7.1% from 2024 to 2032. This growth underscores increasing advancements in medical technology and rising demand for cardiac care solutions.

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5151

Report Highlights

• Left Ventricular Assist Devices (LVAD) dominated the market in 2023, holding a 67% share.
• The bridge-to-transplant application led with a 42% market share in 2023.
• North America emerged as the largest regional market, accounting for 45% of the global share in 2023.
• Rising cases of heart failure (HF) significantly drive the growth of the VAD market.

A ventricular assist device (VAD) is a life-saving implant that helps pump blood from the heart’s lower chambers (ventricles) to the rest of the body when the heart struggles to function effectively. Surgically implanted, a VAD supports patients with severe heart conditions by improving symptoms and enhancing their quality of life for several years.

The Left Ventricular Assist Device (LVAD), the most widely used type, moves oxygen-rich blood from the left ventricle to the rest of the body. Similarly, the Right Ventricular Assist Device (RVAD) pumps oxygen-poor blood from the right ventricle to the lungs for oxygenation. Other devices include biventricular assist devices and pediatric VADs.

VADs can serve various purposes:

• Temporary Support: Acting as a bridge for patients awaiting heart transplants by keeping their heart functioning until a donor heart becomes available.
• Permanent Support (Destination Therapy): Assisting patients who cannot undergo transplants due to age or other health risks, helping them live longer with heart failure.
• Bridge to Recovery: Helping patients with temporary heart failure regain normal heart function.

Key Companies in the Ventricular Assist Device (VAD) Market

• ABIOMED
• Abbott
• Jarvik Heart, Inc.
• Medtronic plc
• Berlin Heart GmbH
• ReliantHeart Inc.
• Cardiac Assist Inc.
• Cirtec
• CorWave SA
• Fineheart

Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/ventricular-assist-device-market-sizing

Access exclusive insight now @ https://www.towardshealthcare.com/price/5151

We’ve prepared a service to support you. Please feel free to contact us at  sales@towardshealthcare.com

Web: https://www.towardshealthcare.com

Visit Dental Specifics: https://www.towardsdental.com

Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare